Studies on nucleoside deaminase. Increase in activity in HeLa cell cultures caused by cytosine arabinoside

R. Meyers, V. G. Malathi, R. P. Cox, R. Silber

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Cytosine arabinoside (ara C) is metabolized via two enzymatic pathways: by phosphorylation to the nucleoside triphosphate arabinosyl CTP or deamination to the inert metabolite uracil arabinoside. Resistance to cytosine arabinoside had been attributed to a decreased synthesis of arabinosyl CTP, the active inhibitor of DNA synthesis. Steuart and Burke suggested the increased deamination of cytosine arabinoside as an alternative mechanism of resistance in patients treated with this drug. In the present study the mechanism for the effect of cytosine arabinoside on nucleoside deaminase activity was investigated in cell culture. HeLa cells grown in medium with added cytosine arabinoside had a 4 fold increase in nucleoside deaminase activity. The increase is dependent on the concentration and time of exposure to cytosine arabinoside. The levels of 4 control enzymes were unaffected by this agent. No difference was found between the properties of nucleoside deaminase purified from cells grown in the presence of cytosine arabinoside and in controls. The early appearance of an increase in nucleoside deaminase in the absence of cell killing made selection of a mutant population improbable. Cycloheximide did not prevent the elevation in nucleoside deaminase indicating that the mechanism, unlike 'classical induction', may not be dependent on the synthesis of a new protein. These studies show that the presence of cytosine arabinoside in tissue culture leads to an increased activity of nucleoside deaminase which could result in accelerated drug degradation. This process may provide a mechanism for resistance to the antimetabolite.

Original languageEnglish (US)
Pages (from-to)5909-5913
Number of pages5
JournalJournal of Biological Chemistry
Volume248
Issue number17
StatePublished - 1973

Fingerprint

Nucleoside Deaminases
Cytarabine
HeLa Cells
Cell culture
Cell Culture Techniques
Cytidine Triphosphate
Deamination
Cells
Arabinofuranosyluracil
Nucleic Acid Synthesis Inhibitors
Antimetabolites
Tissue culture
Phosphorylation
Cycloheximide
Metabolites
Nucleosides
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry

Cite this

Studies on nucleoside deaminase. Increase in activity in HeLa cell cultures caused by cytosine arabinoside. / Meyers, R.; Malathi, V. G.; Cox, R. P.; Silber, R.

In: Journal of Biological Chemistry, Vol. 248, No. 17, 1973, p. 5909-5913.

Research output: Contribution to journalArticle

@article{1cbf3c14fa914973af1866edbd70dd38,
title = "Studies on nucleoside deaminase. Increase in activity in HeLa cell cultures caused by cytosine arabinoside",
abstract = "Cytosine arabinoside (ara C) is metabolized via two enzymatic pathways: by phosphorylation to the nucleoside triphosphate arabinosyl CTP or deamination to the inert metabolite uracil arabinoside. Resistance to cytosine arabinoside had been attributed to a decreased synthesis of arabinosyl CTP, the active inhibitor of DNA synthesis. Steuart and Burke suggested the increased deamination of cytosine arabinoside as an alternative mechanism of resistance in patients treated with this drug. In the present study the mechanism for the effect of cytosine arabinoside on nucleoside deaminase activity was investigated in cell culture. HeLa cells grown in medium with added cytosine arabinoside had a 4 fold increase in nucleoside deaminase activity. The increase is dependent on the concentration and time of exposure to cytosine arabinoside. The levels of 4 control enzymes were unaffected by this agent. No difference was found between the properties of nucleoside deaminase purified from cells grown in the presence of cytosine arabinoside and in controls. The early appearance of an increase in nucleoside deaminase in the absence of cell killing made selection of a mutant population improbable. Cycloheximide did not prevent the elevation in nucleoside deaminase indicating that the mechanism, unlike 'classical induction', may not be dependent on the synthesis of a new protein. These studies show that the presence of cytosine arabinoside in tissue culture leads to an increased activity of nucleoside deaminase which could result in accelerated drug degradation. This process may provide a mechanism for resistance to the antimetabolite.",
author = "R. Meyers and Malathi, {V. G.} and Cox, {R. P.} and R. Silber",
year = "1973",
language = "English (US)",
volume = "248",
pages = "5909--5913",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "17",

}

TY - JOUR

T1 - Studies on nucleoside deaminase. Increase in activity in HeLa cell cultures caused by cytosine arabinoside

AU - Meyers, R.

AU - Malathi, V. G.

AU - Cox, R. P.

AU - Silber, R.

PY - 1973

Y1 - 1973

N2 - Cytosine arabinoside (ara C) is metabolized via two enzymatic pathways: by phosphorylation to the nucleoside triphosphate arabinosyl CTP or deamination to the inert metabolite uracil arabinoside. Resistance to cytosine arabinoside had been attributed to a decreased synthesis of arabinosyl CTP, the active inhibitor of DNA synthesis. Steuart and Burke suggested the increased deamination of cytosine arabinoside as an alternative mechanism of resistance in patients treated with this drug. In the present study the mechanism for the effect of cytosine arabinoside on nucleoside deaminase activity was investigated in cell culture. HeLa cells grown in medium with added cytosine arabinoside had a 4 fold increase in nucleoside deaminase activity. The increase is dependent on the concentration and time of exposure to cytosine arabinoside. The levels of 4 control enzymes were unaffected by this agent. No difference was found between the properties of nucleoside deaminase purified from cells grown in the presence of cytosine arabinoside and in controls. The early appearance of an increase in nucleoside deaminase in the absence of cell killing made selection of a mutant population improbable. Cycloheximide did not prevent the elevation in nucleoside deaminase indicating that the mechanism, unlike 'classical induction', may not be dependent on the synthesis of a new protein. These studies show that the presence of cytosine arabinoside in tissue culture leads to an increased activity of nucleoside deaminase which could result in accelerated drug degradation. This process may provide a mechanism for resistance to the antimetabolite.

AB - Cytosine arabinoside (ara C) is metabolized via two enzymatic pathways: by phosphorylation to the nucleoside triphosphate arabinosyl CTP or deamination to the inert metabolite uracil arabinoside. Resistance to cytosine arabinoside had been attributed to a decreased synthesis of arabinosyl CTP, the active inhibitor of DNA synthesis. Steuart and Burke suggested the increased deamination of cytosine arabinoside as an alternative mechanism of resistance in patients treated with this drug. In the present study the mechanism for the effect of cytosine arabinoside on nucleoside deaminase activity was investigated in cell culture. HeLa cells grown in medium with added cytosine arabinoside had a 4 fold increase in nucleoside deaminase activity. The increase is dependent on the concentration and time of exposure to cytosine arabinoside. The levels of 4 control enzymes were unaffected by this agent. No difference was found between the properties of nucleoside deaminase purified from cells grown in the presence of cytosine arabinoside and in controls. The early appearance of an increase in nucleoside deaminase in the absence of cell killing made selection of a mutant population improbable. Cycloheximide did not prevent the elevation in nucleoside deaminase indicating that the mechanism, unlike 'classical induction', may not be dependent on the synthesis of a new protein. These studies show that the presence of cytosine arabinoside in tissue culture leads to an increased activity of nucleoside deaminase which could result in accelerated drug degradation. This process may provide a mechanism for resistance to the antimetabolite.

UR - http://www.scopus.com/inward/record.url?scp=0015891285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015891285&partnerID=8YFLogxK

M3 - Article

VL - 248

SP - 5909

EP - 5913

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 17

ER -